Boston Scientific recalls pacemakers due to battery issues causing safety mode activation linked to 4 deaths and 2,557 serious injuries, FDA reports.

May 7 () - Boston Scientific has issued an urgent recall to correct several heart devices after ‌the U. Food and Drug ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Individuals that purchased stock in Boston Scientific between July 23, 2025 and February 3, 2026, are now suing the company for artificially inflating its stock prices. Several investors claim that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Boston Scientific BSX0.12%increase; green up pointing triangle said its first-quarter net income roughly doubled as demand continued to grow worldwide for its stents, catheters and other cardiology ...

April 22 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab slashed its annual profit and revenue ‌growth forecasts on Wednesday, a move analysts said could reassure investors ...

Medical device group Boston Scientific has announced a further €75 million investment in its Irish business. The company said the money would drive expansion of research and development capabilities ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

Good morning, and welcome to the Boston Scientific First Quarter 2026 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ...

Shares of Boston Scientific (BSX) traded lower early in the premarket on Wednesday after the MedTech firm lowered its full-year outlook despite reporting better-than-expected financials for Q1 2026.